Unity Biotechnology (UBX) Institutional Ownership → Read this before you buy AI stocks (From InvestorPlace) (Ad) Free UBX Stock Alerts $1.42 -0.06 (-4.05%) (As of 05/20/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Institutional Ownership Changes (13F Filings) for Unity Biotechnology (NASDAQ:UBX)CurrentInstitutional OwnershipPercentage29.49%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$1.37MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$84.45K Get UBX Insider Trade Alerts Want to know when executives and insiders are buying or selling Unity Biotechnology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data UBX Institutional Buying and Selling by Quarter Ad InvestorPlaceRead this before you buy AI stocksBREAKING: New "Formula" Could Lead to Huge AI Payouts When you click here and see what Elon Musk's new invention does… Investors — including multiple billionaires — are now tapping into a unique AI secret to pocket huge, consistent payouts. Starting today, you could siphon a new stream of income from this $3 billion pool of cash. Unity Biotechnology Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/13/2024 Armistice Capital LLC688,000$1.33M0.0%N/A4.100% 8/9/2023 Mayo Clinic124,081$316K0.3%-21.1%0.864% 7/27/2023Virtu Financial LLC17,949$46K0.0%N/A0.125% 5/16/2023 Founders Fund V Management LLC49,172$80K6.2%-90.0%0.342% 5/1/2023 Arete Wealth Advisors LLC10,392$142.30B0.0%N/A0.072% 2/14/2023 683 Capital Management LLC240,000$658K0.1%-91.5%1.691% Get the Latest News and Ratings for UBX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Unity Biotechnology and its competitors with MarketBeat's FREE daily newsletter. 2/9/2023 Mayo Clinic157,198$431K0.2%N/A1.108% 2/8/2023 Prime Capital Investment Advisors LLC11,420$31K0.0%N/A0.080% 2/7/2023Commonwealth Equity Services LLC16,013$43K0.0%-62.8%0.113% 2/6/2023 Arete Wealth Advisors LLC10,392$140.58B0.0%N/A0.073% 2/2/2023 Bailard Inc.17,700$48K0.0%-65.3%0.125% 1/26/2023 Mayo Clinic157,198$431K2.2%N/A1.108% 11/16/2022 Maven Securities LTD100,000$40K0.0%N/A0.705% 11/15/2022 Parkman Healthcare Partners LLC404,092$160K0.0%N/A2.847% 11/15/2022 Laurion Capital Management LP700,000$277K0.0%N/A4.933% 11/15/2022Empery Asset Management LP4,411,645$1.74M10.4%N/A31.090% 11/14/2022 683 Capital Management LLC2,822,449$1.12M0.1%N/A19.888% 11/14/2022 Altium Capital Management LP4,270,000$1.69M0.6%N/A30.087% 11/14/2022UBS Oconnor LLC606,500$240K0.0%N/A4.274% 11/14/2022 Maven Securities LTD100,000$40K0.0%N/A0.705% 11/10/2022 ARCH Venture Management LLC10,048,181$3.97M0.5%N/A75.059% 11/10/2022 Connor Clark & Lunn Investment Management Ltd.162,043$64K0.0%N/A1.210% 11/10/2022 ExodusPoint Capital Management LP509,892$201K0.0%N/A3.808% 5/12/2022 Connor Clark & Lunn Investment Management Ltd.33,917$38K0.0%-64.0%0.049% 5/11/2022 GSA Capital Partners LLP724,202$811K0.1%+4.0%1.047% 2/14/2022 GSA Capital Partners LLP696,115$1.02M0.1%+48.9%1.206% 2/10/2022 Acadian Asset Management LLC278,796$405K0.0%N/A0.483% 2/10/2022 Connor Clark & Lunn Investment Management Ltd.94,282$138K0.0%N/A0.163% 11/16/2021 Two Sigma Advisers LP155,200$466K0.0%+178.6%0.282% 11/16/2021 Two Sigma Investments LP264,216$793K0.0%+64.9%0.479% 11/15/2021 Marshall Wace LLP124,117$373K0.0%+210.7%0.225% 11/15/2021 Franklin Resources Inc.92,900$279K0.0%N/A0.169% 11/15/2021 GSA Capital Partners LLP467,371$1.40M0.1%+127.0%0.848% 11/12/2021 Renaissance Technologies LLC640,700$1.92M0.0%+25.0%1.163% 11/12/2021 Geode Capital Management LLC318,673$956K0.0%+4.1%0.578% 11/9/2021 BlackRock Inc.900,630$2.70M0.0%+2.0%1.635% 11/8/2021 Russell Investments Group Ltd.34,710$103K0.0%-66.8%0.063% 11/4/2021 Deutsche Bank AG168,158$504K0.0%-34.8%0.305% 10/27/2021 Moloney Securities Asset Management LLC21,000$63K0.0%N/A0.038% 10/19/2021 Baillie Gifford & Co.589,111$1.77M0.0%-74.4%1.069% Read this before you buy AI stocks (Ad)BREAKING: New "Formula" Could Lead to Huge AI Payouts When you click here and see what Elon Musk's new invention does… Investors — including multiple billionaires — are now tapping into a unique AI secret to pocket huge, consistent payouts. Starting today, you could siphon a new stream of income from this $3 billion pool of cash.9/3/2021Parametric Portfolio Associates LLC31,399$146K0.0%-30.6%0.057% 8/25/2021 Marshall Wace LLP39,942$186K0.0%N/A0.072% 8/25/2021Marshall Wace North America L.P.14,397$67K0.0%N/A0.026% 8/17/2021 Walleye Capital LLC45,845$213K0.0%N/A0.083% 8/17/2021 Walleye Trading LLC16,378$76K0.0%N/A0.030% 8/17/2021 Millennium Management LLC606,041$2.81M0.0%N/A1.100% 8/17/2021 Boothbay Fund Management LLC10,002$46K0.0%N/A0.018% 8/16/2021 LMR Partners LLP19,158$89K0.0%N/A0.035% 8/16/2021 PDT Partners LLC74,178$344K0.0%+5.6%0.135% 8/16/2021 Occudo Quantitative Strategies LP64,789$301K0.0%N/A0.118% 8/16/2021 Morgan Stanley914,566$4.24M0.0%+445.2%1.660% 8/16/2021 Schonfeld Strategic Advisors LLC17,900$83K0.0%N/A0.032% 8/16/2021 Charles Schwab Investment Management Inc.143,577$667K0.0%-36.6%0.261% 8/16/2021 State Street Corp102,740$477K0.0%-82.8%0.186% 8/16/2021Tibra Equities Europe Ltd80,700$374K0.1%N/A0.146% 8/16/2021 Marshall Wace LLP39,942$186K0.0%N/A0.072% 8/13/2021 Renaissance Technologies LLC512,600$2.38M0.0%N/A0.930% 8/13/2021 Northern Trust Corp61,022$284K0.0%-83.4%0.111% 8/13/2021 Jump Financial LLC33,700$156K0.0%N/A0.061% 8/13/2021 Qube Research & Technologies Ltd45,133$209K0.0%N/A0.082% 8/13/2021 AXA S.A.21,000$97K0.0%-82.2%0.038% 8/13/2021 Geode Capital Management LLC306,245$1.42M0.0%-44.8%0.558% 8/13/2021 Vanguard Group Inc.1,417,933$6.58M0.0%-10.4%2.585% 8/13/2021 FMR LLC4,032,319$18.71M0.0%-2.0%7.351% 8/12/2021 JPMorgan Chase & Co.163,324$758K0.0%+32.7%0.298% 8/12/2021Ergoteles LLC162,100$752K0.0%N/A0.296% 8/11/2021Commonwealth Equity Services LLC12,197$56K0.0%N/A0.022% 8/11/2021 Bank of New York Mellon Corp36,393$169K0.0%-65.5%0.066% 8/11/2021 BlackRock Inc.882,571$4.09M0.0%-69.0%1.609% 8/11/2021 Deutsche Bank AG257,966$1.20M0.0%+857.7%0.470% 8/10/2021 Citigroup Inc.29,607$137K0.0%+12.1%0.054% 8/5/2021 GSA Capital Partners LLP205,882$955K0.1%N/A0.375% 8/4/2021 Russell Investments Group Ltd.104,406$481K0.0%-43.6%0.190% 8/2/2021 Advisor Group Holdings Inc.25,310$116K0.0%-32.0%0.046% 8/2/2021 Baillie Gifford & Co.2,304,111$10.69M0.0%-39.4%4.200% 7/12/202120 20 Capital Management Inc.42,840$199K0.1%N/A0.078% 5/19/2021 Squarepoint Ops LLC14,749$88K0.0%-50.2%0.027% 5/18/2021 Morgan Stanley167,741$1.01M0.0%-57.7%0.306% 5/18/2021 Cubist Systematic Strategies LLC77,772$467K0.0%+52.8%0.142% 5/17/2021 PDT Partners LLC70,233$421K0.0%-10.9%0.128% 5/17/2021 Nuveen Asset Management LLC136,438$819K0.0%+21.3%0.249% 5/17/2021 Goldman Sachs Group Inc.69,537$418K0.0%-46.3%0.127% 5/14/2021 Dimensional Fund Advisors LP48,664$292K0.0%N/A0.089% 5/14/2021 Saturna Capital CORP30,000$180K0.0%-50.0%0.055% 5/13/2021 Barclays PLC29,841$178K0.0%+155.8%0.054% 5/13/2021 Bank of New York Mellon Corp105,539$633K0.0%-8.4%0.193% 5/13/2021 Citigroup Inc.26,405$159K0.0%+14.7%0.048% 5/12/2021 Northern Trust Corp366,844$2.20M0.0%-6.6%0.670% 5/12/2021 Geode Capital Management LLC555,115$3.33M0.0%+18.5%1.013% 5/12/2021 JPMorgan Chase & Co.123,063$739K0.0%+18.6%0.225% Read this before you buy AI stocks (Ad)BREAKING: New "Formula" Could Lead to Huge AI Payouts When you click here and see what Elon Musk's new invention does… Investors — including multiple billionaires — are now tapping into a unique AI secret to pocket huge, consistent payouts. Starting today, you could siphon a new stream of income from this $3 billion pool of cash.5/11/2021 Ballentine Partners LLC31,058$186K0.0%N/A0.057% 5/11/2021 Wilbanks Smith & Thomas Asset Management LLC12,000$72K0.0%N/A0.022% 5/10/2021 Russell Investments Group Ltd.185,076$1.11M0.0%-30.1%0.338% 5/10/2021 Level Four Advisory Services LLC11,710$70K0.0%-22.4%0.021% 5/7/2021 BlackRock Inc.2,844,117$17.06M0.0%-1.3%5.191% 5/6/2021 Alliancebernstein L.P.52,683$316K0.0%+50.5%0.096% 2/24/2021 Bank Julius Baer & Co. Ltd Zurich8,206$43K0.0%N/A0.016% 2/23/2021 Principal Financial Group Inc.10,743$56K0.0%N/A0.020% 2/19/2021 JPMorgan Chase & Co.103,725$543K0.0%+698.4%0.196% 2/17/2021 Jane Street Group LLC102,908$539K0.0%+142.3%0.194% (Data available from 1/1/2016 forward) UBX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of UBX shares? During the previous two years, 18 institutional investors and hedge funds held shares of Unity Biotechnology. The most heavily invested institutionals were Arete Wealth Advisors LLC ($142.30B), ARCH Venture Management LLC ($3.97M), Empery Asset Management LP ($1.74M), Altium Capital Management LP ($1.69M), Armistice Capital LLC ($1.33M), 683 Capital Management LLC ($658K), and Mayo Clinic ($316K).Learn more on UBX's institutional investors. What percentage of Unity Biotechnology stock is owned by institutional investors? 29.49% of Unity Biotechnology stock is owned by institutional investors. Learn more on UBX's institutional investor holdings. Which institutional investors have been buying Unity Biotechnology stock? Of the 15 institutional investors that purchased Unity Biotechnology stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: ARCH Venture Management LLC ($10.05M), Empery Asset Management LP ($4.41M), Altium Capital Management LP ($4.27M), 683 Capital Management LLC ($2.82M), Laurion Capital Management LP ($700K), Armistice Capital LLC ($688K), and UBS Oconnor LLC ($606.50K). How much institutional buying is happening at Unity Biotechnology? Institutional investors have bought a total of 25,187,351 shares in the last 24 months. This purchase volume represents approximately $97.67M in transactions. Which Unity Biotechnology major shareholders have been selling company stock? The following institutional investors have sold Unity Biotechnology stock in the last 24 months: 683 Capital Management LLC ($2.58M), Founders Fund V Management LLC ($442.58K), Bailard Inc. ($33.30K), Mayo Clinic ($33.12K), and Commonwealth Equity Services LLC ($27.00K). How much institutional selling is happening at Unity Biotechnology? Institutional investors have sold a total of 3,118,442 shares in the last 24 months. This volume of shares sold represents approximately $8.05M in transactions. Related Companies: Oncternal Therapeutics Institutional Ownership Biora Therapeutics Institutional Ownership Iterum Therapeutics Institutional Ownership Forte Biosciences Institutional Ownership Lisata Therapeutics Institutional Ownership RenovoRx Institutional Ownership Aptorum Group Institutional Ownership TherapeuticsMD Institutional Ownership Bullfrog AI Institutional Ownership DURECT Institutional Ownership This page (NASDAQ:UBX) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge AlertsWarren Buffett's "mystery stock"Stansberry ResearchThis Could be Your “Big Money” AI MomentInvestorPlaceDigitizing the $11T commodities sector with one tiny stockResource Stock DigestElon to Transform U.S. Economy? Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Unity Biotechnology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.